TScan Therapeutics
TCRX
#10187
Rank
โ‚ฌ44.13 M
Marketcap
0,68ย โ‚ฌ
Share price
-3.24%
Change (1 day)
-58.11%
Change (1 year)

TScan Therapeutics (TCRX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ92.36 Million

According to TScan Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ92.36 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

TScan Therapeutics - Total liabilities on balance sheet (from 2020 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ89.94 M-28.08%
2024-12-31โ‚ฌ0.12 B14%
2023-12-31โ‚ฌ0.10 B18.09%
2022-12-31โ‚ฌ92.9 M285%
2021-12-31โ‚ฌ24.13 M-67.81%
2020-12-31โ‚ฌ74.95 M26.23%
2019-12-31โ‚ฌ59.38 M